We’re proud to see our Chief Medical Officer, Dr. Scott Ramsey, contribute to today’s New York Times piece on the rapid growth of cancer-detecting blood tests.
For health economists, MCD tests presents promise with complexity of modeling population-level benefits and understanding downstream costs and coverage implications. Scott’s comments reinforce the importance of applying rigorous methods to ensure these technologies deliver real value to patients and the healthcare system.
Read the full article here: https://www.nytimes.com/2025/12/02/well/cancer-detecting-blood-tests-are-on-the-rise-do-they-work.html
